Download Kindred Biosciences Images. Kin) shares are trading higher on wednesday after the company announced results from a pivotal efficacy study of parvovirus monoclonal antibody. Stock analysis for kindred biosciences inc (kin:nasdaq cm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

The company is focused on developing therapies for pets.

Wainwright global investment conference, cantor global healthcare conference and lake street best ideas growth conference. Kin), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from its pilot field efficacy study of. The company's product pipeline consists of small. In depth view into kin (kindred biosciences) stock including the latest price, news, dividend history, earnings information and financials.